手部骨关节炎:一个新鲜的外观
Pascal Richette1, Augustin Latourte1
1Service de rhumatologie, hôpital Lariboisière, Paris, France.
Joint bone spine
|October 5, 2023
概括
手部骨关节炎 (OA) 针对炎症的治疗方法,包括生物药物和DMARD,在很大程度上失败了. 一项小型试验显示,口服普雷尼松可为手部炎症性OA爆发提供短期缓解.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 手部骨关节炎 (OA) 是一种常见的疾病,对其成像和治疗干预措施进行了大量研究.
- 图像学研究突出显示了协同炎,子冠状腺胀和手手关节疼痛之间的联系.
- 近年来,人们越来越关注了解手部OA的炎症成分.
研究的目的:
- 对手部症状性骨关节炎的最新治疗策略的疗效进行审查.
- 评估随机对照试验 (RCT) 的结果,调查生物药物和常规疾病修饰性抗风湿药物 (DMARDs).
- 评估炎症在手部OA病原和治疗反应中的作用.
主要方法:
- 随机对照试验 (RCT) 的系统审查,重点是手部OA治疗.
- 对评估抗类素 (IL) -1,抗瘤亡因子 (TNF) 和抗IL-6药物的试验分析.
- 包括试验评估传统的DMARDs,如氧化和短期皮质类固醇使用.
主要成果:
- 涉及生物药物 (抗IL-1,抗TNF,抗IL-6) 和氧化的多个RCT在症状手部OA方面没有比安慰剂显著的益处.
- 六个评价生物药物的RCT没有在症状或结构有效性方面表现出优于安慰剂的优势.
- 一项积极的试验表明,10毫克口服普雷迪尼松6周有效治疗手部OA发作与突炎,但这不是一个长期的解决方案.
结论:
- 目前的生物和常规DMARD疗法在很大程度上对治疗症状手部OA无效.
- 炎症在手部OA的症状爆发中起作用,正如前尼松试验的积极结果所证明的那样.
- 虽然短期使用皮质类固醇可以缓解炎症爆发,但由于潜在的副作用,不建议长期治疗手部骨质炎症.
相关概念视频
Rheumatic Heart Disease I: Introduction
14
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
14
Development of the Limb Synovial Joints
1.4K
Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
1.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14


